{"disease":{"id":"treatment-of-covid-19-in-adults-and-pediatric-patients-12-years-of-age-and-older-who-are-at-high-risk-of-progression-to-severe-covid-19-including-those-who-are-hospitalized-due-to-covid-19-or-who-have-mild-to-moderate-covid-19-with-at-least-one-risk-factor-for-progression-to-severe-covid-19-e-g-older-age-certain-chronic-medical-conditions.md","name":"treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}